Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
New Findings on Diabetes and Cognitive Impairment
Life Expectancy With CVD, CKD, and Diabetes
Macronutrient Intake Impacts Mortality for T2D
MOST POPULAR ARTICLES OF THE MONTH
#1 New Technology Leads to Breakthrough in Metformin Mechanism of Action
#2 5 Key Exercises for People with Diabetes
#3 Did You Know? Metformin, along with dozens of drugs, may have promise against COVID-19
Letter from the Editor
The SGLT-2 inhibitors have made a big change in the way we think about diabetes management, and have emphasized how important a role the kidney plays in glucose management and metabolism. We have gone from a total fear of urinary tract infections to a realization of how these medications help with hypertension and heart failure, and it seems that even though most benefits and side effects are class-wide, there are individual differences that can make picking one entity over the other worthwhile for patients.
To help you select the best SGLT-2 inhibitor for your particular patient, our intern, Maya S. Palmer, Doctor of Pharmacy Candidate, Florida A&M University, has prepared a chart for the purpose.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Tool for Your Practice
Our chart can help you choose the best SGLT-2 inhibitor for your particular patient.
Download the SGLT-2 inhibitors chart (PDF format)
TOP STORIES — Diabetes News and Research
Studies show that patients with type 2 diabetes are more likely to exhibit reduced cognitive function after a stroke.
Explore the detriments associated with two of the most common diabetes comorbidities.
Study finds proportions of carbs, proteins and fats in the diet have differing effects on mortality risk for men and women with type 2.